Kyle Robinson

kyle_pic

Ph.D. Candidate (Chemistry)

  • 2009-2013 B.Sc. (Hons.) Bio-organic Chemistry, McGill University, Montreal, Quebec

 

Email: krobin24(at)chem.ubc.ca
Phone: 604-822-4626

 

RESEARCH INTEREST

Chagas disease is a potentially fatal parasitic disease, originating in Latin America, which currently affects nearly 10 million people worldwide. Existing treatment options against the infectious pathogen, Trypanosoma cruzi, are limited in effectiveness and can cause severe side effects.

My research focuses on the development of alternative treatment options against the pathogenic enzyme T. cruzi trans-sialidase, through specific mechanism based inactivation. This is to be achieved by the synthesis of 9-subsititued 2,3-difluorosialic acid derivatives to generate potent and selective inhibition towards the parasitic enzyme.